Structure-Based Optimization of Imidazopyridine Derivatives as Selective and Orally Bioavailable Phosphodiesterase 10A Inhibitors with Reduced Blood–Brain Barrier Penetration for the Treatment of Idiopathic Pulmonary Fibrosis
用户6X7Ch8WUQ_gI
8天前
36
10
已完结
1. 系统已在2025-11-30 22:06:59对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c02293
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02293
其他信息:
出版社: American Chemical Society (ACS)
作者: Fengcai Zhang; Han Yuan; Siqi Yao; Dongjing Yang; Jiafei Wu; Jianwen Chen; Quan Wang; Yi-You Huang; Hai-Bin Luo; Lei Guo
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c02293
